Format

Send to:

Choose Destination
See comment in PubMed Commons below
Radiology. 1994 Dec;193(3):753-5.

Biopsy of inoperable pancreatic tumors does not adversely influence patient survival time.

Author information

  • 1Department of Diagnostic Imaging, Middlesex Hospital.

Abstract

PURPOSE:

To determine the influence of pancreatic biopsy on the survival times of patients with inoperable tumors of the pancreas.

MATERIALS AND METHODS:

One hundred seventy patients were examined; results of histologic analysis confirmed pancreatic malignancy in 119. The biopsy and nonbiopsy groups were comparable for age, sex, the presence of liver metastases, and nodal status.

RESULTS:

No statistically significant difference was demonstrated between the survival time for the biopsy group (median, 23 weeks) and that for the nonbiopsy group (median, 22 weeks). The estimated relative risk for death (biopsy group compared with nonbiopsy group) was 0.85 (95% confidence limits = 0.61, 1.18).

CONCLUSION:

Pancreatic biopsy does not appear to adversely influence survival time for patients with inoperable pancreatic tumors. Because histologic examination aids clinical management, biopsy should be part of the diagnostic work-up for patients with suspected inoperable pancreatic carcinoma.

PMID:
7526415
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Atypon
    Loading ...
    Write to the Help Desk